Total Health-related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers.

07:00 EST 1st February 2018 | BioPortfolio

Summary of "Total Health-related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers."

This study aimed to examine a detailed breakdown of costs (absenteeism, presenteeism, and medical/pharmaceutical expenses), of the employees in four pharmaceutical companies in Japan.


Journal Details

This article was published in the following journal.

Name: Journal of occupational and environmental medicine
ISSN: 1536-5948


DeepDyve research library

PubMed Articles [36649 Associated PubMed Articles listed on BioPortfolio]

Work Absenteeism and Presenteeism Loss in Patients with Non-cardiac Chest Pain.

To assess work absenteeism and presenteeism, and to identify biopsychosocial predictors of these outcomes in workers with non-cardiac chest pain (NCCP).

The association of adolescent spinal-pain-related absenteeism with early adulthood work absenteeism: A six-year follow-up data from a population-based cohort.

Objectives Spinal (ie, back and neck) pain often develops as early as during adolescence and can set a trajectory for later life. However, whether early-life spinal-pain-related behavioral responses o...

Are people living with HIV less productive at work?

Health problems may cause decreased productivity among working people. It is unclear if this also applies for people living with HIV (PLWH). This cross-sectional study compares data of PLWH of one of ...

Administrative Costs Associated With Physician Billing and Insurance-Related Activities at an Academic Health Care System.

Administrative costs in the US health care system are an important component of total health care spending, and a substantial proportion of these costs are attributable to billing and insurance-relate...

Hospital costs in relation to body-mass index in 1·1 million women in England: a prospective cohort study.

Excess weight is associated with poor health and increased health-care costs. However, a detailed understanding of the effects of excess weight on total hospital costs and costs for different health c...

Clinical Trials [11989 Associated Clinical Trials listed on BioPortfolio]

Kent State University / Price Chopper Employee Wellness Study

This is a comprehensive randomized cluster hand-hygiene improvement intervention to reduce: self-reported acute respiratory tract infections (ARI) / influenza-like-illness (ILI) and gastro...

Multiple-component Workplace FRamed Intervention to Decrease Occupational Muscle Pain - FRIDOM

Several RCT studies have aimed to reduce either musculoskeletal disorders, sickness presenteeism, sickness absenteeism or a combination of these among females with high physical work deman...

Interventions to Increase Workplace Wellness

Behaviour changes such as improving nutrition, increasing physical activity, and decreasing obesity are linked with lower mortality and morbidity and fewer cancers. Health promotion progra...

MobilWise: Mobile Phone Remote Coaching After Worksite Joint ADventure Exposure

MobilWise, a worksite physical activity intervention for employees at high risk for knee osteoarthritis (OA), is being tested in a developmental randomized controlled trial at a collaborat...

Incidence and Risk Factor of Drug Related Problem Detected in Inpatient

Drug Related Problem (DRP) is defined as an event that may potentially affect the health outcomes in the patients. DRPs can occur at all stages of the medication usage process starting fro...

Medical and Biotech [MESH] Definitions

That portion of total HEALTH CARE COSTS borne by an individual's or group's employing organization.

The amounts spent by individuals, groups, nations, or private or public organizations for total health care and/or its various components. These amounts may or may not be equivalent to the actual costs (HEALTH CARE COSTS) and may or may not be shared among the patient, insurers, and/or employers.

The actual costs of providing services related to the delivery of health care, including the costs of procedures, therapies, and medications. It is differentiated from HEALTH EXPENDITURES, which refers to the amount of money paid for the services, and from fees, which refers to the amount charged, regardless of cost.

The personal cost of acute or chronic disease. The cost to the patient may be an economic, social, or psychological cost or personal loss to self, family, or immediate community. The cost of illness may be reflected in absenteeism, productivity, response to treatment, peace of mind, QUALITY OF LIFE, etc. It differs from HEALTH CARE COSTS, meaning the societal cost of providing services related to the delivery of health care, rather than personal impact on individuals.

Total pharmaceutical services provided by qualified PHARMACISTS. In addition to the preparation and distribution of medical products, they may include consultative services provided to agencies and institutions which do not have a qualified pharmacist.

Quick Search


DeepDyve research library

Searches Linking to this Article